Long-acting drug effectively prevents HIV-like infection in monkeys
Date: January 15, 2015
Source: Rockefeller University
Summary: HIV infection can be prevented with regimens of antiretroviral drugs, however, their effectiveness depends on a patient's ability to take the pills as prescribed. HIV researchers hope cabotegravir would make compliance easier for some by requiring only one injection every three months.
. . .
A clinical trial testing long-acting cabotegravir's safety and acceptability has already begun at multiple U.S. sites including The Rockefeller University Hospital. Meanwhile two new studies, including one conducted by researchers at the Aaron Diamond AIDS Research Center (ADARC) and Rockefeller University, published today (January 15) in Science Translational Medicine, show that long-acting cabotegravir injections are highly protective in a monkey model of vaginal transmission of a virus similar to HIV.
